Endogenous cortisol levels influence exposure therapy in spider phobia

Behaviour Research and Therapy

Volumn 60, Issue , 2014, Pages 39-45

  Lass Hennemann, Johanna ^a   Michael, Tanja ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Anxiety disorders; Cortisol; Exposure therapy; Extinction learning; Glucocorticoids; Spider phobia

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; CLINICAL ASSESSMENT; HAIR LEVEL; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE HAIR LEVEL; HYDROCORTISONE SALIVA LEVEL; MAJOR CLINICAL STUDY; PHOBIA; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOTHERAPY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SALIVA LEVEL; SCORING SYSTEM; SPIDER PHOBIA; TREATMENT DURATION; TREATMENT RESPONSE; ANIMAL; BEHAVIOR THERAPY; BLOOD; CONTROLLED STUDY; FEMALE; MALE; PHOBIC DISORDERS; PSYCHOLOGY; SPIDER; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANIMALS; FEMALE; HUMANS; HYDROCORTISONE; IMPLOSIVE THERAPY; MALE; PHOBIC DISORDERS; SPIDERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904471798     PISSN: 00057967     EISSN: 1873622X     Source Type: Journal    
DOI: 10.1016/j.brat.2014.06.009     Document Type: Article

References (42)

1. Bentz D., Michael T., de Quervain D.J., Wilhelm F.H. Enhancing exposure therapy for anxiety disorders with glucocorticoids: from basic mechanisms of emotional learning to clinical applications. Journal of Anxiety Disorders 2010, 24:223-230.
2. Bentz D., Michael T., Wilhelm F.H., Hartmann F.R., Kunz S., von Rohr I.R., et al. Influence of stress on fear memory processes in an aversive differential conditioning paradigm in humans. Psychoneuroendocrinology 2013, 38:1186-1197.
3. Choy Y., Fyer A.J., Lipsitz J.D. Treatment of specific phobia in adults. Clinical Psychology Review 2007, 27:266-286.
4. Dressendorfer R.A., Kirschbaum C., Rohde W., Stahl F., Strasburger C.J. Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. Journal of Steroid Biochemistry and Molecular Biology 1992, 43:683-692.
5. Field A.P. Is conditioning a useful framework for understanding the development and treatment of phobias?. Clinical Psychology Review 2006, 26:857-875.
6. Gustafsson P.E., Gustafsson P.A., Ivarsson T., Nelson N. Diurnal cortisol levels and cortisol response in youths with obsessive-compulsive disorder. Neuropsychobiology 2008, 57:14-21.
7. Hautzinger M., Bailer M., Wollar H., Keller F. BDI Becks Depressions Inventar Testhandbuch 1995, Hans Huber, Bern.
8. Hermans D., Craske M.G., Mineka S., Lovibond P.F. Extinction in human fear conditioning. Biological Psychiatry 2006, 60:361-368.
9. Hofmann S.G., Pollack M.H., Otto M.W. Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. CNS Drug Reviews 2006, 12:208-217.
10. Hofmann S.G., Smits J.A. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. Journal of Clinical Psychiatry 2008, 69:621-632.
11. Horne J.A., Ostberg O. Aself-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. International Journal of Chronobiology 1976, 4:97-110.
12. Kaiser H., Kley H.K. Cortisontherapie. Corticoide in Klinik und Praxis 2002, Georg Thieme Verlag, Stuttgart. 9th ed.
13. Kellner M., Wiedemann K., Yassouridis A., Muhtz C. Non-response of cortisol during stressful exposure therapy in patients with obsessive-compulsive disorder - preliminary results. Psychiatry Research 2012, 199:111-114.
14. Kirschbaum C., Hellhammer D.H. Salivary cortisol in psychobiological research: an overview. Neuropsychobiology 1989, 22:150-169.
15. Kirschbaum C., Tietze A., Skoluda N., Dettenborn L. Hair as a retrospective calendar of cortisol production - increased cortisol incorporation into hair in the third trimester of pregnancy. Psychoneuroendocrinology 2009, 34:32-37.
16. Krohne H.W., Egloff B., Kohlmann C.W., Tausch A. Untersuchung mit einer deutschen Form der Positive and Negative Affect Schedule (PANAS). Diagnostica 1996, 42:139-156.
17. Laux L., Glanzmann P., Schaffner P., Spielberger C.D. Das State-Trait-Angstinventar. Theoretische Grundlagen und Handanweisungen 1981, Beltz Test GmbH, Weinheim.
18. Maldonado E.F., Fernandez F.J., Trianes M.V., Wesnes K., Petrini O., Zangara A., et al. Cognitive performance and morning levels of salivary cortisol and alpha-amylase in children reporting high vs. low daily stress perception. Spanish Journal of Psychology 2008, 11:3-15.
19. Margraf J. Mini-DIPS. Diagnostisches Kurzinterview bei psychischen Störungen 1994, Springer, Heidelberg.
20. Merz C.J., Tabbert K., Schweckendiek J., Klucken T., Vaitl D., Stark R., et al. Investigating the impact of sex and cortisol on implicit fear conditioning with fMRI. Psychoneuroendocrinology 2010, 35:33-46.
21. Merz C.J., Tabbert K., Schweckendiek J., Klucken T., Vaitl D., Stark R., et al. Oral contraceptive usage alters the effects of cortisol on implicit fear learning. Hormones and Behavior 2012, 62:531-538.
22. Michael T., Ehlers A. Lernpsychologische Grundlagen der Verhaltenstherapie. Lehrbuch der Verhaltenstherapie 2009, Vol. 3:101-113. Springer, Heidelberg.
23. Michael T., Munsch S., Margraf J. Exposition und Konfrontation. Enzyklopädie der Psychologie - Psychotherapeutische Methoden 2009, 325-386. Hogrefe, Göttingen. M. Hautzinger, P. Pauli (Eds.).
24. Michael T., Zetsche U., Margraf J. Epidemiology of anxiety disorders. Psychiatry 2007, 6:136-142.
25. Mineka S., Oehlberg K. The relevance of recent developments in classical conditioning to understanding the etiology and maintenance of anxiety disorders. Acta Psychologica 2008, 127:567-580.
26. Norton P.J., Price E.C. Ameta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. Journal of Nervous and Mental Disease 2007, 195:521-531.
27. Ost L.G. One-session treatment for specific phobias. Behaviour Research and Therapy 1989, 27:1-7.
28. Otto M.W., Basden S.L., Leyro T.M., McHugh R.K., Hofmann S.G. Clinical perspectives on the combination of D-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disorders. CNS Spectrums 2007, 12:51-56. 59-61.
29. Preuss D., Schoofs D., Wolf O.T. Associations between endogenous cortisol levels and emotional memory in young women: influence of encoding instructions. Stress 2009, 12:379-387.
30. Pruessner J.C., Kirschbaum C., Meinlschmid G., Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003, 28:916-931.
31. Putman P., Van Honk J., Kessels R.P., Mulder M., Koppeschaar H.P. Salivary cortisol and short and long-term memory for emotional faces in healthy young women. Psychoneuroendocrinology 2004, 29:953-960.
32. de Quervain D.J., Aerni A., Schelling G., Roozendaal B. Glucocorticoids and the regulation of memory in health and disease. Frontiers in Neuroendocrinology 2009, 30:358-370.
33. de Quervain D.J., Bentz D., Michael T., Bolt O.C., Wiederhold B.K., Margraf J., et al. Glucocorticoids enhance extinction-based psychotherapy. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:6621-6625.
34. Rabinak C.A., Angstadt M., Sripada C.S., Abelson J.L., Liberzon I., Milad M.R., et al. Cannabinoid facilitation of fear extinction memory recall in humans. Neuropharmacology 2013, 64:396-402.
35. Rauch S.A., Eftekhari A., Ruzek J.I. Review of exposure therapy: a gold standard for PTSD treatment. Journal of Rehabilitation Research and Development 2012, 49:679-687.
36. Shearer S.L. Recent advances in the understanding and treatment of anxiety disorders. Primary Care 2007, 34:475-504. v-vi.
37. Siegmund A., Koster L., Meves A.M., Plag J., Stoy M., Strohle A. Stress hormones during flooding therapy and their relationship to therapy outcome in patients with panic disorder and agoraphobia. Journal of Psychiatric Research 2011, 45:339-346.
38. Soravia L.M., Heinrichs M., Aerni A., Maroni C., Schelling G., Ehlert U., et al. Glucocorticoids reduce phobic fear in humans. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:5585-5590.
39. Suris A., North C., Adinoff B., Powell C.M., Greene R. Effects of exogenous glucocorticoid on combat-related PTSD symptoms. Annals of Clinical Psychiatry 2010, 22:274-279.
40. Szymanski J., O'Donohue W. Fear of spiders questionnaire. Journal of Behavior Therapy and Experimental Psychiatry 1995, 26:31-34.
41. Van Honk J., Kessels R.P., Putman P., Jager G., Koppeschaar H.P., Postma A. Attentionally modulated effects of cortisol and mood on memory for emotional faces in healthy young males. Psychoneuroendocrinology 2003, 28:941-948.
42. Vervliet B. Learning and memory in conditioned fear extinction: effects of D-cycloserine. Acta Psychologica 2008, 127:601-613.